Table 5 Operative methods, operative outcomes and questionnaire in de novo stress urinary incontinence (SUI) group (n = 24) and no SUI group (n = 53).

From: Predictors for de novo stress urinary incontinence following pelvic reconstruction surgery with transvaginal single-incisional mesh

 De novo SUI group (n = 24)No SUI group (n = 53)p valueOR (95% CI)
Device
Anterior mesh13 (54.2)31 (58.5)0.721.19 (0.45–3.15)
Anterior and posterior mesh10 (41.7)15 (28.3)0.250.55 (0.20–1.51)
Posterior mesh1 (4.2)7 (13.2)0.423.50 (0.41–0.17)
Concomitant hysterectomy13 (54.2)35 (66.0)0.321.65 (0.62–4.40)
Pre-operative symptoms
Urinary frequency13 (54.2)17 (32.1)0.070.40 (0.15–1.07)
UI9 (37.5)13 (24.5)0.240.54 (0.19–1.53)
Urodynamic diagnosis
Occult USI7 (29.2)2 (3.8)0.00310.0 (2.00–50.0)
SUI history10 (41.7)4 (7.6)0.0019.1 (2.38–33.3)
DO8 (33.3)15 (28.3)0.660.79 (0.28–2.23)
BOO9 (37.5)23 (43.4)0.701.10 (0.40–3.12)
MUCP drop after reduction8 (33.3)16 (30.2)0.730.76 (0.20–2.89)
OABSS ≥ 610 (41.7)17 (32.1)0.410.66 (0.24–1.79)
  1. Fisher’s exact test and χ2 test were performed for categorical variables.
  2. The univariate logistic regression was applied for odds ratios and 95% confidence intervals.
  3. *OR: odds ratios; CI: confidence intervals; UI: urgency incontinence; USI: urodynamic stress incontinence; DO: detrusor overactivity; BOO: bladder outlet obstruction; MUCP: maximum urethral closure pressure; OABSS: overactive bladder symptom score.